{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T16:19:47Z","timestamp":1778948387733,"version":"3.51.4"},"reference-count":15,"publisher":"Japanese Society of Internal Medicine","issue":"17","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2015]]},"DOI":"10.2169\/internalmedicine.54.4148","type":"journal-article","created":{"date-parts":[[2015,8,31]],"date-time":"2015-08-31T22:09:50Z","timestamp":1441058990000},"page":"2241-2244","source":"Crossref","is-referenced-by-count":1,"title":["Optic Neuritis Associated with Myelodysplastic Syndrome Accompanied by Eosinophilic Crisis"],"prefix":"10.2169","volume":"54","author":[{"given":"Joji","family":"Nagasaki","sequence":"first","affiliation":[{"name":"Hematology, Graduate School of Medicine, Osaka City University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsutaka","family":"Nishimoto","sequence":"additional","affiliation":[{"name":"Hematology, Graduate School of Medicine, Osaka City University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirohisa","family":"Nakamae","sequence":"additional","affiliation":[{"name":"Hematology, Graduate School of Medicine, Osaka City University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiko","family":"Nakane","sequence":"additional","affiliation":[{"name":"Hematology, Graduate School of Medicine, Osaka City University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideo","family":"Koh","sequence":"additional","affiliation":[{"name":"Hematology, Graduate School of Medicine, Osaka City University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kumiko","family":"Yoshimoto","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Science, Graduate School of Medicine, Osaka City University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunihiko","family":"Shiraki","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Science, Graduate School of Medicine, Osaka City University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayuki","family":"Hino","sequence":"additional","affiliation":[{"name":"Hematology, Graduate School of Medicine, Osaka City University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Saif MW, Hopkins JL, Gore SD. Autoimmune phenomena in patients with myelodysplastic syndromes and chronic myelomonocytic leukemia. Leuk Lymphoma 43: 2083-2092, 2002.","DOI":"10.1080\/1042819021000016186"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Giannouli S, Voulgarelis M, Zintzaras E, Tzioufas AG, Moutsopoulos HM. Autoimmune phenomena in myelodysplastic syndromes: a 4-yr prospective study. Rheumatology 43: 626-632, 2004.","DOI":"10.1093\/rheumatology\/keh136"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Enright H, Jacob HS, Vercellotti G, Howe R, Belzer M, Miller W. Paraneoplastic autoimmune phenomena in patients with myelodysplastic syndromes: response to immunosuppressive therapy. Br J Haematol 91: 403-408, 1995.","DOI":"10.1111\/j.1365-2141.1995.tb05310.x"},{"key":"4","unstructured":"4. Castro M, Conn DL, Su WPD, Garton JP. Rheumatic manifestations in myelodysplastic syndromes. J Rheumatol 18: 721-727, 1991."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Kezuka T, Usui N, Suzuki E, Wakasugi K, Usui M. Ocular complications in myelodysplastic syndromes as preleukemic disorders. Jpn J Ophthalmol 49: 377-383, 2005.","DOI":"10.1007\/s10384-005-0228-6"},{"key":"6","unstructured":"6. Brouzas D, Charakidas A, Ladas I, Apostolopoulos M. Nonarteritic anterior ischemic optic neuropathy associated with chronic anemia: a case series of myelodysplastic syndrome patients. Clin Ophthalmol 3: 133-137, 2009."},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Ayanlarbatuman O, Shevitz J, Traub UC, Murphy S, Sajewski D. Lymphocyte interleukin-2 production and responsiveness are altered in patients with primary myelodysplastic syndrome. Blood 70: 494-500, 1987.","DOI":"10.1182\/blood.V70.2.494.494"},{"key":"8","unstructured":"8. San Miguel JF, Hern&aacute;ndez JM, Gonz&aacute;lez-Sarmiento R, et al. Acute leukemia after a primary myelodysplastic syndrome: immunophenotypic, genotypic, and clinical characteristics. Blood 78: 768-774, 1991."},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Colombat PH, Renoux M, Lamagnere JP, Renoux G. Immunological indexes in myelodysplastic syndromes. Cancer 61: 1075-1081, 1988.","DOI":"10.1002\/1097-0142(19880315)61:6<1075::AID-CNCR2820610604>3.0.CO;2-E"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Kordasti SY, Afzali B, Lim Z, et al. Il-17-producing CD4<sup>+<\/sup> t cells, pro-inflammatory cytokines and apoptosis are increased in low risk myelodysplastic syndrome. Br J Haematol 145: 64-72, 2009.","DOI":"10.1111\/j.1365-2141.2009.07593.x"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Venge P, Dahl R, H&auml;llgren R. Enhancement of factor-XII dependent reactions by eosinophil cationic protein. Thromb Res 14: 641-649, 1979.","DOI":"10.1016\/0049-3848(79)90119-1"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Moore PM, Harley JB, Fauci AS. Neurologic dysfunction in the idiopathic hypereosinophilic syndrome. Ann Intern Med 102: 109-114, 1985.","DOI":"10.7326\/0003-4819-102-1-109"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Gordon MH. Remarks on Hodgkin's disease, a pathogenic agent in the glands, and its application in diagnosis. Br Med J 1: 641-644, 1933.","DOI":"10.1136\/bmj.1.3771.641"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Monaco S, Lucci B, Laperchia N, et al. Polyneuropathy in hypereosinophilic syndrome. Neurology 38: 494-496, 1988.","DOI":"10.1212\/WNL.38.3.494"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Rot A, Krieger M, Brunner T, Bischoff SC, Schall TJ, Dahinden CA. Rantes and macrophage inflammatory protein 1-alpha induce the migration and activation of normal human eosinophil granulocytes. J Exp Med 176: 1489-1495, 1992.","DOI":"10.1084\/jem.176.6.1489"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/54\/17\/54_54.4148\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,7]],"date-time":"2020-09-07T20:25:38Z","timestamp":1599510338000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/54\/17\/54_54.4148\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":15,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.54.4148","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015]]}}}